Targeting pattern recognition receptors in cancer immunotherapy.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 1, p. 29, doi. 10.1007/s11523-012-0213-1
- By:
- Publication type:
- Article
Works matching IS 17762596 AND DT 2012 AND VI 7 AND IP 1
Results: 8
1
2
Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival.
- Published in:
- 2012
- By:
- Publication type:
- journal article
3
Targeting regulatory T cells.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 1, p. 15, doi. 10.1007/s11523-012-0208-y
- By:
- Publication type:
- Article
4
Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?
- Published in:
- Targeted Oncology, 2012, v. 7, n. 1, p. 3, doi. 10.1007/s11523-012-0207-z
- By:
- Publication type:
- Article
5
A review on various targeted anticancer therapies.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 1, p. 69, doi. 10.1007/s11523-012-0212-2
- By:
- Publication type:
- Article
6
Recent successes of cancer immunotherapy: a new dimension in personalized medicine?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
7
Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 1, p. 55, doi. 10.1007/s11523-012-0210-4
- By:
- Publication type:
- Article
8
Advancement in the research on vascular endothelial growth inhibitor (VEGI).
- Published in:
- Targeted Oncology, 2012, v. 7, n. 1, p. 87, doi. 10.1007/s11523-012-0206-0
- By:
- Publication type:
- Article